Documente Academic
Documente Profesional
Documente Cultură
Syakib Bakri
Condition Mechanism
Anorexia Inadequate protein or
calorie intake
Metabolic acidosis Stimulation of amino acid
and protein degradation
Infection/inflamatory Stimulation of protein
illness degradation
Diabetes Stimulation of protein
degradation and
suppression of protein
synthesis
Nutritional profile during CKD
2. Obese ++ + + ++
* first 3 months
Malnutrition in CKD
Type II
Type I
uremic malnutrition/wasting
Pupim L, Ikizler TA: Uremic malnutrition: New insights into old problem.
Semin Dial 2003; 16: 224-232
Type of malnutrition in Kidney Disease
Factors Type 1 Type 2
Associated with uremic Associated with MIA
syndrome syndrome
NKF-DOQI clinical practice guidelines for HD - Predialysis stabilized serum albumin : monthly.
adequacy ( HD and DP) [71] Serum albumin be 40g/L by the bromocresol
green methode
- BW : percentage of ususal postdialysis (HD) or
post-drain (DP) BW, monthly : percentage of
standard (NANHESII) BW, every 4 mo
- SGA every 6 mo
- Dietary interview and/or diary nPNA, every 6 mo
Lack of compliance
Enteral Nutrition
Dietary Oral
IDPN If EN is not possible:
counselling supplements Central venous PN
No improvement No improvement
Clinical Nutrition.2009;28:401-414
Interventions to prevent and/or treat PEW in CKD patients
(1) Pre-dialysis patients
- Optimal dietary protein and calorie intake
- Optimal timing for initiation of dialysis, before onset of indices of malnutrition
(2) Dialysis patients
- Appropriate amount of dietary protein intake (> 1.2 g/kg/day) along with nutritional counseling to
encourage increased intake
- Optimal dose of dialysis (Kt/V > 1.4 or URR > 65%)
- Use of biocompatible dialysis membranes
- Enteral or intradialytic parenteral nutritional supplements (hemodialysis) and amino acid dialysate
(peritoneal dialysis) if oral intake is not sufficient
- Growth factors (experimental):
Recombinant human growth hormone
Recombinant human insulin-like growth factor-I
(3) Transplant patients:
- Appropriate amount of dietary protein intake
- Avoidance of excessive use of immunosuppressives
- Early reinitiation of dialytic therapy with proper steroid tapering in patients with chronic rejection
Kidney Int. 1996;50:343-357
Summary of Clinical Practice Guideline for Nutrition in CKD
PEW : A state of loss of muscle and fat tissues together with metabolic
changes not amenable to dietary intervention in the context of CKD.
Associated with degree of co-morbidities and inflammation. Increased
energy expenditure. Fat is underutilized - muscle is wasted Markedly low
s-albumin, pre-albumin, s-creatinine , High CRP . Correction of acidosis,
inflammation, nutritional interventions, adequate, dialysis doses
Etiology PEW in CKD